Study links lifestyle choices and gender to severity of fatty liver disease in workers

Study investigates the correlation between lifestyle factors, gender, inflammation, liver dysfunction, and metabolic abnormalities with fatty liver disease severity, revealing that men are at higher risk and lifestyle choices significantly impact the disease’s progression.

Novel Treatment Appears to Show Benefit in ALS

DENVER — A novel treatment candidate for amyotrophic lateral sclerosis (ALS) met its primary safety and secondary endpoints in the phase IIb PARADIGM trial. ALS

April 19, 2024

FDA Rejects Drug for Chronic Cough

The FDA declined to approve oral gefapixant for treating chronic cough, Merck announced on Wednesday. In its complete response letter, “the FDA concluded that Merck’s

December 22, 2023

Second Drug OK’d for Ultra-Rare Neurodegenerative Disease

The FDA gave the green light to levacetylleucine (Aqneursa) as a stand-alone treatment for Niemann-Pick disease type C (NPC), just days after approving the first

September 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.